heavy%20menstrual%20bleeding
HEAVY MENSTRUAL BLEEDING
Heavy menstrual bleeding is prolonged (>7 days) or excessive (>10 mL) uterine bleeding occurring at regular intervals over several menstrual cycles.
It is menstrual blood loss that is excessive and interferes with patient's physical, emotional, social and quality of life.
It is also referred to as menorrhagia or hypermenorrhea.
It is a common problem in women of reproductive age that usually causes anemia.
Uterine fibroids and polyps are the most common pathology identified.

Heavy%20menstrual%20bleeding Signs and Symptoms

Introduction

  • Common problem in women of reproductive age (increases with age) which usually causes anemia
    • Most common symptom experienced by women with bleeding disorder

Definition

  • Prolonged (>7 days) or excessive (>80 mL) uterine bleeding occurring at regular intervals over several menstrual cycles
    • Menstrual blood loss that is excessive and interferes with patient’s physical, emotional, social and quality of life

Etiology

  • Causes of abnormal uterine bleeding (AUB) are categorized into the following groups:
    • Discrete structural abnormalities that can be examined with imaging techniques and/or histopathology
      • PALM: polyp, adenomyosis, leiomyoma1, malignancy and hyperplasia
    • Non-structural abnormalities that cannot be defined by imaging or histopathology
      • COEIN: coagulopathy (eg von Willebrand’s disease), ovulatory dysfunction, endometrial, iatrogenic, not yet classified
      • Iatrogenic includes AUB associated with use of hormonal or non-hormonal medications (eg anticoagulation therapy), intrauterine systems or devices, or other local or systemic agents
      •  Not yet classified includes conditions that are rare or ill-defined
    • Other causes include chronic endometrial infection, arteriovenous malformation, hypothyroidism, obesity  
    • 1Please see Leiomyomas Disease Management Chart for details
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
2 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 6 days ago
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).